From new technologies to awareness campaigns, the radiology industry has taken great strides to address concerns about radiation dose. Is it enough?
From adopting new technologies to updating protocols, the radiology industry has taken great strides in recent years to address concerns about radiation dose. Imaging professionals are pledging to increase awareness among peers and patients, and a recent study even examines the possibility of an antioxidant pill protecting patients from radiation-induced cancer.
Is the industry doing enough to reduce dose? What else can be done?
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.